Replies to post #1550 on Globalist Reality Report

[DragonBear]

I checked the JAMA site your listed, and all the studies are outdated from last year. Reported in 2021 but outdated since news trials confirm efficacy of hydroxy.

The conclusion as reported in 2021 are not outdated. The virus or disease pathology has not changed- outside of new more dangerous variants. HCQ still has the same molecular formula.

since news trials confirm efficacy of hydroxy.

List a few published in a reputable science journal such as NEJM, or JAMA.

Also, your last study had to do w/hospital patients. Hydroxy is not used for those hospitalized, it is for early onset patients.

Wrong. The Brazilian trial hydroxychloroquine or lopinavir-ritonavir was used as outpatient with those having mild disease.

Anutter trial concludes

Hydroxychloroquine did not substantially reduce symptom severity in outpatients with early, mild COVID-19.

Note the words "outpatient", "early",and "mild".

Now why don't you provide a few references from scientific journals. Because I can keep pulling up articles concluding HCQ doesn't do anything ... one article after another.

BTW - are you prepared to tell us how on the molecular level the mRNA vaccines are dangerous? Maybe it's the sucrose stabilizer in the Pfizer vaccine? LOL

[janice shell]

Was this the JAMA article you were thinking of?

April 22, 2021

Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19

The TOGETHER Randomized Clinical Trial[/I]

Question Does hydroxychloroquine or lopinavir-ritonavir, administered as a 9-day course, prevent COVID-19–associated hospitalization in patients with COVID-19?

Findings In this trial that included 685 patients, rates of COVID-19–associated hospitalization in patients treated with hydroxychloroquine or lopinavir-ritonavir were not significantly different compared with those who received placebo.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779044?resultClick=1